Envision Report

Published January 6, 2018

Australia Hospital Supplies Market- Size, Outlook, Trends, and Forecasts (2018 – 2024)

Request Free Sample Report!

Australia Hospital medical equipment and supplies indulge various instruments, tools and medical consumables that are used in hospitals. This market in Australia has been increasing substantially over the past few years. Australia Hospital supplies market which is valued at USD xx million in 2018 to be raised to USD xx million by 2024 with CAGR of xx%  in the forecast period of 2018-2024.

Australia Hospital Supplies Market Share:

Compared to the past years, Hospital Supplies has undergone a predominant change in the markets of Australia. Hospital supplies are now available in different medical centres, institutions, and hospitals. Rapid growth in awareness about HAI’s (Hospital Acquired Infections) is a significant element which is driving this market in Australia.

Australia Hospital Supplies Market Size:

There is a wide range of fields in which these Hospital Supplies are used such as  Sterilization & Disinfectant Equipment, Disposable Hospital Supplies, Mobility Aids & Transportation Equipment and others. As there are significant applications, the market size related to hospital supplies is, even more, more prominent in Australia.

Australia Hospital Supplies Market Growth:

The markets related to the Hospital Supplies is having the inclined growth. As the principal players like  Novartis Pharmaceuticals Australia Pty Ltd, Novo Nordisk Pharmaceuticals Pty Ltd, Organon Australia Pty Ltd,  have seen the excellent increase from past years in dealing with the Hospital Supplies and along with these other companies related to hospital supplies have also seen a decent amount of growth in Australia.

Australia Hospital Supplies Market Industry Analysis:

Type segments Australia Hospital Supplies Market. Whereby type these are sub-segmented as Sterilization & Disinfectant Equipment, Disposable Hospital Supplies, Mobility Aids & Transportation Equipment, Patient Examination Devices,  Operating Room Equipment and others.

Australia Hospital Supplies Market Outlook:

Due to the growth of health consciousness among people, an ageing population, increase in hospital number, demand for the hospital supplies, the growth of different types of dreadful diseases has led hospital supplies to have a unique outlook where the market parameters and marginal values are taken into consideration.

Australia Hospital Supplies Market Trends:

There is the significant number of companies dealing with the hospital supplies market in Australia. Among them, the major players are Novartis Pharmaceuticals Australia Pty Ltd, Novo Nordisk Pharmaceuticals Pty Ltd, Organon Australia Pty Ltd, Otsuka Pharmaceutical Australia Pty Ltd, Parke Davis Pty Ltd. Among these the products dealing with the Solvay Pharmaceuticals like Anti-acid drugs, hemodialysis. Comparatively Reckitt & Colman Pharmaceuticals is the products like Dettol, Strepsils, Air Wick.

Australia Hospital Supplies Market Research Report includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on YearOnYear
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as
  • Novartis Pharmaceuticals Australia Pty Ltd
  • Parke Davis Pty Ltd
  • Novo Nordisk Pharmaceuticals Pty Ltd
  • Organon Australia Pty Ltd
  • Otsuka Pharmaceutical Australia Pty Ltd

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1   Drivers

4.2   Restraints

4.3   Opportunities

4.4   Challenges

Chapter 5 Market Segmentation Analysis

Chapter 6  Market Segmentation by type

6.1 Sterilization & Disinfectant Equipment

6.2  Disposable Hospital Supplies

6.3  Mobility Aids & Transportation Equipment

6.4  Patient Examination Devices

6.5  Operating Room Equipment

Chapter 7 Market Segmentation by geography

7.1 Australia

Chapter  8 Competitive Landscape

8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

8.2 Strategies Adopted By Top Companies

8.3 Market Share Analysis

Chapter 9 Company Profiles

9.1 Solvay Pharmaceuticals

9.1.1 Introduction

9.1.2 Company overview

9.1.3 Financial  Performance

9.1.4 Product Benchmarking

9.2 Parke Davis Pty Ltd

9.3 Organon Australia Pty Ltd

9.4 Novo Nordisk Pharmaceuticals Pty Ltd

9.5 Otsuka Pharmaceutical Australia Pty Ltd

9.6 Reckitt & Colman Pharmaceuticals

9.7 Pfizer Pty Ltd

9.8 Rhone-Poulenc Rorer Australia Pty Ltd

9.9 Novartis Pharmaceuticals Australia Pty Ltd

9.10 Schering Pty Ltd

9.11 Schering-Plough Pty Ltd

9.12 Roche Products Pty Ltd

9.13 Sanofi-Synthelabo Australia Pty Limited

9.14 REM SYSTEMS Pty Ltd

9.15 RP Scherer Holdings Pty Ltd

9.16 Serono Australia Pty Ltd

9.17 Searle – A Division of Monsanto Australia Ltd

9.18 Smith & Nephew Pty Ltd

9.19 Sigma Pharmaceuticals Pty Ltd

Chapter 10  Market Estimates and Forecast

10.1 Market Estimation and Forecast 2018-2024(USD Billion)

10.1.1 Market Estimates and Forecast by  type 2018-2024 (USD Billion)

10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Billion)

Chapter 11 Market Insights

11.1 Insights of Industry Experts

11.2 Investment  Opportunities

11.3 Analyst Opinion

Chapter 12 Appendix

12.1 List of Tables

12.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.